0001638599-20-000655.txt : 20200702
0001638599-20-000655.hdr.sgml : 20200702
20200702180807
ACCESSION NUMBER: 0001638599-20-000655
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200630
FILED AS OF DATE: 20200702
DATE AS OF CHANGE: 20200702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GANDOLFO JOHN P
CENTRAL INDEX KEY: 0001200155
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38365
FILM NUMBER: 201011283
MAIL ADDRESS:
STREET 1: 62 TERRACE ROAD
CITY: WAYNE
STATE: NJ
ZIP: 07470
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EYENOVIA, INC.
CENTRAL INDEX KEY: 0001682639
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 471178401
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 295 MADISON AVENUE,
STREET 2: SUITE 2400
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 813-766-9539
MAIL ADDRESS:
STREET 1: 295 MADISON AVENUE,
STREET 2: SUITE 2400
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
doc4_6777.xml
PRIMARY DOCUMENT
X0306
4
2020-06-30
0
0001682639
EYENOVIA, INC.
EYEN
0001200155
GANDOLFO JOHN P
C/O EYENOVIA, INC.
295 MADISON AVENUE, SUITE 2400
NEW YORK
NY
10017
0
1
0
0
Chief Financial Officer
Common Stock, par value $.0001
2000
D
Stock Option (right to buy)
2.72
2020-06-30
4
A
0
114774
0.00
A
2030-06-02
Common Stock
114774
114774
D
Stock Option (right to buy)
8.72
2028-04-16
Common Stock
71200
71200
D
Stock Option (right to buy)
6.20
2028-07-24
Common Stock
24842
24842
D
Stock Option (right to buy)
3.11
2029-08-16
Common Stock
53402
53402
D
This stock option was granted by the Issuer's Board of Directors on June 3, 2020, subject to stockholder approval of the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan (the "Plan"). The Issuer's stockholders approved the Plan on June 30, 2020. One-third of the option becomes exercisable on June 3, 2021 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
The option became exercisable as to 1,977 shares on May 16, 2018 and becomes exercisable in equal 1,977 share amounts on each of the 35 one-month anniversaries thereafter.
One-third of the option became exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
One-third of the option becomes exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
/s/ S. Halle Vakani, Attorney-in-Fact
2020-07-02